These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9303509)

  • 1. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation.
    Asanza CG; García-Monzón C; Clemente G; Salcedo M; García-Buey L; García-Iglesias C; Bañares R; Alvarez E; Moreno-Otero R
    Hepatology; 1997 Sep; 26(3):755-63. PubMed ID: 9303509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
    J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
    García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R
    Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the effector T-cell response and viremia in symptomatic chronic hepatitis C.
    Mosnier JF; Pham BN; Scoazec JY; Dubois S; Marcellin P; Martinot-Peignoux M; Degos F; Erlinger S; Degott C
    Arch Pathol Lab Med; 1998 May; 122(5):416-22. PubMed ID: 9593342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant reactivation of hepatitis C virus: lymphocyte infiltration and the expression of adhesion molecules and their ligands in liver allografts.
    Lipson K; Lappalainen M; Höckerstedt K; Lautenschlager I
    APMIS; 2006 Apr; 114(4):247-54. PubMed ID: 16689823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
    Gaweco AS; Wiesner RH; Porayko M; Rustgi VK; Yong S; Hamdani R; Harig J; Chejfec G; McClatchey KD; Van Thiel DH
    Hepatology; 2000 May; 31(5):1183-91. PubMed ID: 10796896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
    Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
    Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
    Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
    Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.